Author:
Lu Zenghui,Yuan Yue,Han Qiang,Wang Yu,Liang Qionglin
Abstract
AbstractBenefiting from the complex system composed of various constituents, medicament portions, species, and places of origin, traditional Chinese medicine (TCM) possesses numerous customizable and adaptable efficacies in clinical practice guided by its theories. However, these unique features are also present challenges in areas such as quality control, screening active ingredients, studying cell and organ pharmacology, and characterizing the compatibility between different Chinese medicines. Drawing inspiration from the holistic concept, an integrated strategy and pattern more aligned with TCM research emerges, necessitating the integration of novel technology into TCM modernization. The microfluidic chip serves as a powerful platform for integrating technologies in chemistry, biology, and biophysics. Microfluidics has given rise to innovative patterns like lab-on-a-chip and organoids-on-a-chip, effectively challenging the conventional research paradigms of TCM. This review provides a systematic summary of the nature and advanced utilization of microfluidic chips in TCM, focusing on quality control, active ingredient screening/separation, pharmaceutical analysis, and pharmacological/toxicological assays. Drawing on these remarkable references, the challenges, opportunities, and future trends of microfluidic chips in TCM are also comprehensively discussed, providing valuable insights into the development of TCM.
Funder
Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
National Key R&D Program of China
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference167 articles.
1. Lyu M, Fan G, Xiao G, Wang T, Xu D, Gao J, et al. Traditional Chinese medicine in COVID-19. Acta Pharm Sin B. 2021;11(11):3337–63.
2. Luo G, Liang Q, Wang Y. Fingerprinting of Chinese materia medica: quality evaluation. Ltd: Quality Control and New Drug Development. Chemical Industry Press Co.; 2009. p. 1–20.
3. Yang W, Zhang Y, Wu W, Huang L, Guo D, Liu C. Approaches to establish Q-markers for the quality standards of traditional Chinese medicines. Acta Pharm Sin B. 2017;7(4):439–46.
4. Luo G, Wang Y, Liang Q, Liu Q. Systems biology for traditional Chinese medicine. Hoboken: Wiley; 2012. p. 1–33.
5. Li S. Network pharmacology evaluation method guidance - draft. World J Tradit Chin Med. 2021;7(1):146–54.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献